EXPOSURE-RESPONSE RELATIONSHIP OF SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) IN PATIENTS WITH ACTIVE CROHN'S DISEASE AND ULCERATIVE COLITIS: ANALYSIS FROM A MULTICENTER, RANDOMIZED CONTROLLED PIVOTAL TRIAL

Byong Duk Ye  1     Jaroslaw Leszczyszyn  2     Robert Dudkowiak  2     Adi Lahat  3     Beata Gawdis-Wojnarska  4     Aldis Pukitis  5     Marek Horynski     Katalin Farkas     Jaroslaw Kierkuś     Maciej Kowalski     Stefan Schreiber     Walter Reinisch     Sang Joon Lee     Sung Hyun Kim     Jee Hye Suh     Mi Rim Kim     Han Na Kim     Shomron Ben-Horin    
1 University of Ulsan College of Medicine, Asan Medical Center,Seoul,Korea (Republic of)
2 Melita Medical,Wroclaw,Poland
3 Sheba Medical Center, Sackler School of Medicine, Tel Aviv University,Ramat Gan,Israel
4 Twoja Przychodnia - Szczecińskie Centrum Medyczne,Szczecin,Poland
5 Pauls Stradins Clinical Univers

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing